Abstract
Purpose
The aim of this study was to estimate the incidence and predictors of venous thromboembolism (VTE) in medically ill hospitalized elderly cancer patients in a single Korean tertiary hospital.
Methods
Patients were examined for deep vein thrombosis (DVT) by duplex and color Doppler ultrasonography (DUS) of both legs between days 5 and 14 of their hospital stays. The primary endpoint was the incidence of VTE by day 14, which was determined via a composite of DVT detected by routine DUS and symptomatic VTE.
Results
A total of 140 patients with 31 hematologic and 109 nonhematologic malignancies were analyzed. The median age was 73 years, and 45.7% of the patients were female. The median length of hospital stay was 12 days. The modified Padua prediction score (PPS) ≥ 4 was 92.9%. The incidence of VTE by day 14 was 7.1%, including six proximal and four distal DVT cases. Being female, having a length of hospital stay of ≥ 13 days, and having a modified Padua prediction score of ≥ 6 were risk factors of VTE in univariate analysis. The incidence of VTE was 2.3%, 7.3%, and 41.7% in patients with 0–1, 2, and 3 of these risk factors, respectively.
Conclusion
The incidence of VTE in medically ill hospitalized elderly cancer patients was lower in Korean patients than in Western patients. However, the risk of VTE in those with more than two risk factors (female, long length of hospitalization, and high PPS) increased considerably, and pharmacologic thromboprophylaxis is warranted in these cases.
Similar content being viewed by others
References
Gussoni G, Frasson S, La Regina M, Di Micco P, Monreal M (2013) Three-month mortality rate and clinical predictors in patients with venous thromboembolism and cancer. Findings from the RIETE registry. Thromb Res 131:24–30. https://doi.org/10.1016/j,thromres.2012.10.007
White RH, Zhou H, Murin S, Harvey D (2005) Effect of ethnicity and gender on the incidence of venous thromboembolism in a diverse population in California in 1996. Thromb Haemost 93:298–305. https://doi.org/10.1160/TH04-08-0506
Blom JW, Vanderschoot JP, Oostindier MJ, Osanto S, van der Meer FJ, Rosendaal FR (2006) Incidence of venous thrombosis in a large cohort of 66,329 cancer patients: results of a record linkage study. J Thromb Haemost 4:529–535. https://doi.org/10.1111/j.1538-7836.2006.01804.x
Walker AJ, Card TR, West J, Crooks C, Grainge MJ (2013) Incidence of venous thromboembolism in patients with cancer - a cohort study using linked United Kingdom databases. Eur J Cancer 49:1404–1413. https://doi.org/10.1016/j.ejca.2012.10.021
Naess IA, Christiansen SC, Romundstad P, Cannegieter SC, Rosendaal FR, Hammerstrom J (2007) Incidence and mortality of venous thrombosis: a population-based study. J Thromb Haemost 5:692–699. https://doi.org/10.1111/j.1538-7836.2007.02450.x
Streiff MB et al (2017) NCCN clinial practice guidelines in oncology: cancer-associated venous thromboembolic disease. https://www.nccn.org/professionals/physician_gls/default.aspx#vte. Accessed 23 June, 2017
Lyman GH, Bohlke K, Khorana AA, Kuderer NM, Lee AY, Arcelus JI, Balaban EP, Clarke JM, Flowers CR, Francis CW, Gates LE, Kakkar AK, Key NS, Levine MN, Liebman HA, Tempero MA, Wong SL, Somerfield MR, Falanga A, American Society of Clinical Oncology (2015) Venous thromboembolism prophylaxis and treatment in patients with cancer: american society of clinical oncology clinical practice guideline update 2014. J Clin Oncol 33:654–656. https://doi.org/10.1200/JCO.2014.59.7351
Mandala M, Falanga A, Roila F, Group EGW (2011) Management of venous thromboembolism (VTE) in cancer patients: ESMO Clinical Practice Guidelines. Ann Oncol 22(Suppl 6):vi85–vi92. https://doi.org/10.1093/annonc/mdr392
Kahn SR, Lim W, Dunn AS, Cushman M, Dentali F, Akl EA, Cook DJ, Balekian AA, Klein RC, Le H et al (2012) Prevention of VTE in nonsurgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 141:e195S–e226S. https://doi.org/10.1378/chest.11-2296
Cohen AT, Tapson VF, Bergmann JF, Goldhaber SZ, Kakkar AK, Deslandes B, Huang W, Zayaruzny M, Emery L, Anderson FA Jr (2008) Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet 371:387–394. https://doi.org/10.1016/S0140-6736(08)60202-0
Kahn SR, Panju A, Geerts W, Pineo GF, Desjardins L, Turpie AG, Glezer S, Thabane L, Sebaldt RJ (2007) Multicenter evaluation of the use of venous thromboembolism prophylaxis in acutely ill medical patients in Canada. Thromb Res 119:145–155. https://doi.org/10.1016/j.thromres.2006.01.011
Seddighzadeh A, Shetty R, Goldhaber SZ (2007) Venous thromboembolism in patients with active cancer. Thromb Haemost 98:656–661
Zwicker JI, Rojan A, Campigotto F, Rehman N, Funches R, Connolly G, Webster J, Aggarwal A, Mobarek D, Faselis C, Neuberg D, Rickles FR, Wun T, Streiff MB, Khorana AA (2014) Pattern of frequent but nontargeted pharmacologic thromboprophylaxis for hospitalized patients with cancer at academic medical centers: a prospective, cross-sectional, multicenter study. J Clin Oncol 32:1792–1796. https://doi.org/10.1200/JCO.2013.53.5336
Lee LH, Gallus A, Jindal R, Wang C, Wu CC (2017) Incidence of venous thromboembolism in Asian populations: a systematic review. Thromb Haemost 117:2243–2260. https://doi.org/10.1160/TH17-02-0134
Hong J, Lee JH, Yhim HY, Choi WI, Bang SM, Lee H, Oh D (2013) Incidence of venous thromboembolism in Korea from 2009 to 2013. PLoS One 13:e0191897. https://doi.org/10.1371/journal.pone.0191897
White RH, Keenan CR (2009) Effects of race and ethnicity on the incidence of venous thromboembolism. Thromb Res 123(Suppl 4):S11–S17. https://doi.org/10.1016/S0049-3848(09)70136-7
Yhim HY, Lee J, Lee JY, Lee JO, Bang SM (2017) Pharmacological thromboprophylaxis and its impact on venous thromboembolism following total knee and hip arthroplasty in Korea: a nationwide population-based study. PLoS One 12:e0178214. https://doi.org/10.1371/journal.pone.0178214
Lee J, Kim SC, Kim SJ, Oh JY, Lee HK, Yum HK, Kim YK, Hong SB, Park MS, Hwang SC, Yoon HK, Kim HR, Cho JH, Park S, Yoo CG (2014) Prevention of venous thromboembolism in medical intensive care unit: a multicenter observational study in Korea. J Korean Med Sci 29:1572–1576. https://doi.org/10.3346/jkms.2014.29.11.1572
World Health Organization Western Pacific Region (2010) The Asia-Pacific perspective: redefining obesity and its treatment. http://www.wpro.who.int/nutrition/documents/docs/Redefiningobesity.pdf Accessed February 2017
Barbar S, Noventa F, Rossetto V, Ferrari A, Brandolin B, Perlati M, De Bon E, Tormene D, Pagnan A, Prandoni P (2010) A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score. J Thromb Haemost 8:2450–2457. https://doi.org/10.1111/j.1538-7836.2010.04044.x
Decousus H, Tapson VF, Bergmann JF, Chong BH, Froehlich JB, Kakkar AK, Merli GJ, Monreal M, Nakamura M, Pavanello R, Pini M, Piovella F, Spencer FA, Spyropoulos AC, Turpie AG, Zotz RB, Fitzgerald G, Anderson FA, IMPROVE Investigators (2011) Factors at admission associated with bleeding risk in medical patients: findings from the IMPROVE investigators. Chest 139:69–79. https://doi.org/10.1378/chest.09-3081
Kearon C, Akl EA, Comerota AJ, Prandoni P, Bounameaux H, Goldhaber SZ, Nelson ME, Wells PS, Gould MK, Dentali F, Crowther M, Kahn SR (2012) Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141:e419S–e496S. https://doi.org/10.1378/chest.11-2301
Cohen AT, Davidson BL, Gallus AS, Lassen MR, Prins MH, Tomkowski W, Turpie AG, Egberts JF, Lensing AW (2006) Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial. BMJ 332:325–329. https://doi.org/10.1136/bmj.38733.466748.7C
Leizorovicz A, Cohen AT, Turpie AG, Olsson CG, Vaitkus PT, Goldhaber SZ (2004) Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients. Circulation 110:874–879. https://doi.org/10.1161/01.CIR.0000138928.83266.24
Samama MM, Cohen AT, Darmon JY, Desjardins L, Eldor A, Janbon C, Leizorovicz A, Nguyen H, Olsson CG, Turpie AG, Weisslinger N (1999) A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in medical patients with enoxaparin study group. N Engl J Med 341:793–800. https://doi.org/10.1056/NEJM199909093411103
Alikhan R, Cohen AT, Combe S, Samama MM, Desjardins L, Eldor A, Janbon C, Leizorovicz A, Olsson CG, Turpie AG (2003) Prevention of venous thromboembolism in medical patients with enoxaparin: a subgroup analysis of the MEDENOX study. Blood Coagul Fibrinolysis 14:341–346
Yamashita Y, Shiomi H, Morimoto T, Yoneda T, Yamada C, Makiyama T, Kato T, Saito N, Shizuta S, Ono K, Kimura T (2017) Asymptomatic lower extremity deep vein thrombosis- clinical characteristics, management strategies, and long-term outcomes. Circ J 81:1936–1944. https://doi.org/10.1253/circj.CJ-17-0445
Alcalay A, Wun T, Khatri V, Chew HK, Harvey D, Zhou H, White RH (2006) Venous thromboembolism in patients with colorectal cancer: incidence and effect on survival. J Clin Oncol 24:1112–1118. https://doi.org/10.1200/JCO.2005.04.2150
Khorana AA, Francis CW, Culakova E, Kuderer NM, Lyman GH (2007) Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients. Cancer 110:2339–2346. https://doi.org/10.1002/cncr.23062
Park LC, Woo SY, Kim S, Jeon H, Ko YH, Kim SJ, Kim WS (2012) Incidence, risk factors and clinical features of venous thromboembolism in newly diagnosed lymphoma patients: results from a prospective cohort study with Asian population. Thromb Res 130:e6–e12. https://doi.org/10.1016/j.thromres.2012.03.019
Oh SY, Kim JH, Lee KW, Bang SM, Hwang JH, Oh D, Lee JS (2008) Venous thromboembolism in patients with pancreatic adenocarcinoma: lower incidence in Asian ethnicity. Thromb Res 122:485–490. https://doi.org/10.1016/j.thromres.2007.12.015
Choi S, Lee KW, Bang SM, Kim S, Lee JO, Kim YJ, Kim JH, Park YS, Kim DW, Kang SB, Kim JS, Oh D, Lee J (2011) Different characteristics and prognostic impact of deep-vein thrombosis / pulmonary embolism and intraabdominal venous thrombosis in colorectal cancer patients. Thromb Haemost 106:1084–1094. https://doi.org/10.1160/TH11-07-0505
Kniffin WD Jr, Baron JA, Barrett J, Birkmeyer JD, Anderson FA Jr (1994) The epidemiology of diagnosed pulmonary embolism and deep venous thrombosis in the elderly. Arch Intern Med 154:861–866
Kang MJ, Ryoo BY, Ryu MH, Koo DH, Chang HM, Lee JL, Kim TW, Kang YK (2012) Venous thromboembolism (VTE) in patients with advanced gastric cancer: an Asian experience. Eur J Cancer 48:492–500. https://doi.org/10.1016/j.ejca.2011.11.016
Glare P, Virik K, Jones M, Hudson M, Eychmuller S, Simes J, Christakis N (2003) A systematic review of physicians' survival predictions in terminally ill cancer patients. BMJ 327:195–198. https://doi.org/10.1136/bmj.327.7408.195
Zabrocka E, Wojtukiewicz MZ, Sierko E (2018) Thromboprophylaxis in cancer patients in hospice. Adv Clin Exp Med 27:283–289. https://doi.org/10.17219/acem/64593
Funding
This study was supported by a grant from Seoul National University Bundang Hospital Research Fund (grant no.04-2012-003).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
This study was approved by the Institutional Review Board at SNUBH (IRB number: B-1201-144-007). Written informed consent was obtained from the patients prior to study entry, and this study was conducted in accordance with the principles of the Declaration of Helsinki.
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Lee, JO., Lee, J.Y., Chun, E.J. et al. Incidence and predictors of venous thromboembolism in medically ill hospitalized elderly cancer patients: a prospective observational study. Support Care Cancer 27, 2507–2515 (2019). https://doi.org/10.1007/s00520-018-4537-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-018-4537-y